This is a pilot placebo-controlled randomised phase II trial to assess the feasibility , safety and toxicity of an oral loading dose of Vitamin D ( 500,000 IU ) followed by an oral dose of 50,000 IU of Vitamin D monthly for 2 years in patients who have been treated for cutaneous melanoma by wide excision of the primary .